Hyperthrombotic Milieu in COVID-19 Patients
COVID-19 infection has protean systemic manifestations. Experience from previous coronavirus outbreaks, including the current SARS-CoV-2, has shown an augmented risk of thrombosis of both macrovasculature and microvasculature. The former involves both arterial and venous beds manifesting as stroke,...
| Main Authors: | , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
MDPI AG
2020
|
| Online Access: | https://hdl.handle.net/1721.1/128363 |